Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis
暂无分享,去创建一个
Patrick Callier | Ange-Line Bruel | Sophie Nambot | Yannis Duffourd | Laurence Faivre | Christel Thauvin-Robinet | Emilie Tisserant | Anne-Laure Mosca-Boidron | Julien Thevenon | Pierre Vabres | Jean-Baptiste Rivière | J. Rivière | J. Thevenon | L. Faivre | C. Philippe | C. Thauvin-Robinet | Y. Duffourd | Pierre Vabres | É. Tisserant | P. Callier | J. St‐Onge | Virginie Carmignac | P. Kuentz | T. Jouan | Alice Masurel-Paulet | V. Carmignac | Daphné Lehalle | Judith St-Onge | A. Bruel | D. Lehalle | F. T. Mau-Them | A. Mosca-Boidron | M. Lefebvre | S. Nambot | N. Jean-Marçais | M. Chevarin | Paul Kuentz | Nolwenn Jean-Marçais | Mathilde Lefebvre | Salima El Chehadeh-Djebbar | Christophe Philippe | Frederic Tran Mau-Them | Thibaud Jouan | Martin Chevarin | Charlotte Poé | Antonio Vitobello | A. Vitobello | C. Poé | A. Masurel‐Paulet | Anne-Laure Mosca-Boidron | S. E. Chehadeh-Djebbar
[1] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[2] Donna M. Muzny,et al. Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation , 2017, The New England journal of medicine.
[3] Orion J. Buske,et al. The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery , 2015, Human mutation.
[4] Peter Szolovits,et al. Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.
[5] K. Helbig,et al. Classification of Genes: Standardized Clinical Validity Assessment of Gene–Disease Associations Aids Diagnostic Exome Analysis and Reclassifications , 2017, Human mutation.
[6] Boris Yamrom,et al. The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.
[7] Julia Wynn,et al. The usefulness of whole-exome sequencing in routine clinical practice , 2014, Genetics in Medicine.
[8] J. Rivière,et al. Autosomal recessive mutations in THOC6 cause intellectual disability: syndrome delineation requiring forward and reverse phenotyping , 2017, Clinical genetics.
[9] Tomas W. Fitzgerald,et al. Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.
[10] S. McCandless,et al. The burden of genetic disease on inpatient care in a children's hospital. , 2004, American journal of human genetics.
[11] Joshua L. Deignan,et al. A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories , 2016, Genetics in Medicine.
[12] Karynne E. Patterson,et al. The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities. , 2015, American journal of human genetics.
[13] V. Dulieu,et al. 9q33.3q34.11 microdeletion: new contiguous gene syndrome encompassing STXBP1, LMX1B and ENG genes assessed using reverse phenotyping , 2015, European Journal of Human Genetics.
[14] Eric Vilain,et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. , 2014, JAMA.
[15] A Rötig,et al. Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data , 2017, Clinical genetics.
[16] S. Julia,et al. Rett‐like phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and first familial case of CDKL5‐related disease , 2017, Clinical genetics.
[17] Dustin Baldridge,et al. The Exome Clinic and the Role of Medical Genetics Expertise in Interpretation of Exome Sequencing Results , 2017, Genetics in Medicine.
[18] Clara Gaff,et al. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement , 2017, Genetics in Medicine.
[19] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[20] Jared Evans,et al. Exome Sequencing Identifies Pathogenic and Modifier Mutations in a Child With Sporadic Dilated Cardiomyopathy , 2015, Journal of the American Heart Association.
[21] A. Toutain,et al. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. , 2014, American journal of human genetics.
[22] I. Helbig,et al. Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy , 2016, Genetics in Medicine.
[23] J. Rivière,et al. Homozygous FIBP nonsense variant responsible of syndromic overgrowth, with overgrowth, macrocephaly, retinal coloboma and learning disabilities , 2016, Clinical genetics.
[24] W. Grody,et al. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.
[25] R. Pfundt,et al. Dominant variants in the splicing factor PUF60 cause a recognizable syndrome with intellectual disability, heart defects and short stature , 2016, European Journal of Human Genetics.
[26] Magalie S Leduc,et al. Molecular findings among patients referred for clinical whole-exome sequencing. , 2014, JAMA.
[27] S. Antonarakis,et al. Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy. , 2016, American journal of human genetics.
[28] G. Zampino,et al. Bi-allelic Mutations in KLHL7 Cause a Crisponi/CISS1-like Phenotype Associated with Early-Onset Retinitis Pigmentosa. , 2018, American journal of human genetics.
[29] P. Shannon,et al. Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.
[30] J. Rivière,et al. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole‐exome sequencing as a first‐line diagnostic test , 2016, Clinical genetics.
[31] Alejandro Sifrim,et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data , 2015, The Lancet.
[32] Allyn McConkie-Rosell,et al. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders , 2013, Genetics in Medicine.
[33] Matthew S. Lebo,et al. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. , 2016, American journal of human genetics.
[34] D. G. MacArthur,et al. Guidelines for investigating causality of sequence variants in human disease , 2014, Nature.
[35] D. Ledbetter,et al. Recommendations for the integration of genomics into clinical practice , 2016, Genetics in Medicine.
[36] L. Vissers,et al. Genetic studies in intellectual disability and related disorders , 2015, Nature Reviews Genetics.
[37] Heidi L Rehm,et al. ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.
[38] Arrigo Schieppati,et al. Why rare diseases are an important medical and social issue , 2008, The Lancet.
[39] Robert C. Green,et al. Erratum: Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716300593) (10.1016/j.ajhg.2016.03.024)) , 2016 .
[40] G. Bejerano,et al. Systematic reanalysis of clinical exome data yields additional diagnoses: implications for providers , 2016, Genetics in Medicine.
[41] Murim Choi,et al. Wiedemann-Steiner Syndrome With 2 Novel KMT2A Mutations , 2017, Journal of child neurology.
[42] F. Zou,et al. Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center’s Experience , 2015, Front. Pediatr..
[43] J. Rivière,et al. Autosomal recessive truncating MAB21L1 mutation associated with a syndromic scrotal agenesis , 2017, Clinical genetics.